Advancement and Innovation in Measurement of Language Development and Predictors (R21 Clinical Trial Not Allowed)
Can you apply?
This grant is for early-stage research on language development measurement and prediction in human populations, offered by the National Institutes of Health (NIDA). Eligible applicants include academic institutions, research hospitals, nonprofits with research capacity, and individual researchers at qualifying institutions in the United States. The R21 mechanism supports exploratory/developmental projects that are novel or investigate new methodologies; clinical trials are explicitly not allowed. Applicants must have research credentials and institutional research support (such as CTSA affiliation or institutional IRB capacity). International collaborations are permitted but the principal investigator and research team must be U.S.-based or working at a U.S. institution.
This grant is for early-stage research on language development measurement and prediction in human populations, offered by the National Institutes of Health (NIDA). Eligible applicants include academic institutions, research hospitals, nonprofits with research capacity, and individual researchers at qualifying institutions in the United States. The R21 mechanism supports exploratory/developmental projects that are novel or investigate new methodologies; clinical trials are explicitly not allowed. Applicants must have research credentials and institutional research support (such as CTSA affiliation or institutional IRB capacity). International collaborations are permitted but the principal investigator and research team must be U.S.-based or working at a U.S. institution.
Program description
The purpose of this notice of funding opportunity (NOFO) is to encourage community-engaged research that broadens the conceptualization of qualities of the environment that can support language development in children and that focuses on the development of novel measures of childrens language development. The overall goal is to build the number of strengths-focused, culturally and linguistically responsive, and generalizable toolsto further our understanding of childrens language development and/or impairment, and predictors thereof.
Who can apply
Eligible applicants
- 501(c)(3) Public Charity
- City / Municipal Government
- Colleges (all higher ed)
- County Government
- Nonprofits
- Private University
- Public Authority
- Public K-12 School
- Public University
- Small Business (SBA-defined)
- Special District
- State Government
- Tribal Nation
- Tribal Organization
Demographic focus
Details
This grant is for early-stage research on language development measurement and prediction in human populations, offered by the National Institutes of Health (NIDA). Eligible applicants include academic institutions, research hospitals, nonprofits with research capacity, and individual researchers at qualifying institutions in the United States. The R21 mechanism supports exploratory/developmental projects that are novel or investigate new methodologies; clinical trials are explicitly not allowed. Applicants must have research credentials and institutional research support (such as CTSA affiliation or institutional IRB capacity). International collaborations are permitted but the principal investigator and research team must be U.S.-based or working at a U.S. institution.
How to apply
Application links
Required documents
- SF-424 (R&R) application form and required NIH face pages
- Project Narrative (research strategy: Significance, Innovation, Approach)
- Biographical Sketch (applicant and key personnel, NIH format)
- Budget Justification and Budget form (SF-424 R&R Budget Component)
- Facilities & Administrative (F&A) Costs documentation
- Institutional Support Letter (from department/division chair or IRB confirming research capacity)
- Letters of Collaboration (if applicable)
- Preliminary data or pilot study results (strongly recommended)
- IRB approval documentation or protocol summary (if human subjects involved)
- Data management and sharing plan (required by NIH)
Program contact
- 👤 National Institutes of Health
- 📧 grantsinfo@nih.gov
- 📞 301-402-2541
Funding track record
Recent awards under CFDA 93.865 from the last 3 years — real organizations that won funding through this same program.
Top 10 Largest Recent Awards
-
$1,059,454,555
-
$719,372,575
-
$276,059,721
-
$155,556,396
-
$155,482,198
-
$103,665,364
-
$74,151,078
-
$71,490,911
-
$52,238,426
-
$47,450,377
Top States by Funding
- WA 1 awards $1,059.5M
- NC 7 awards $921.5M
- MD 4 awards $493.9M
- MA 3 awards $190.0M
- PA 3 awards $145.1M
Source: USAspending.gov — federal spending transparency. Data covers last 3 years.
Funding history
Annual funding for this program — Federal obligations (CFDA 93.865). How funding has trended year over year.
| 2024 | $1,282,226,682 | |
| 2025 | $1,333,391,690 | |
| 2026 est. | $184,920,723 |
FAQ
Who can apply for this R21 grant?
Academic institutions, research hospitals, nonprofit research organizations, and individual researchers at U.S. institutions. You must have institutional research infrastructure and appropriate research credentials. Clinical researchers with institutional affiliation are typically eligible.
Are clinical trials allowed under this R21?
No. The grant explicitly excludes clinical trial research. This is an exploratory/developmental award focused on measurement innovation and methodological advancement.
What is the deadline and how long does the review process take?
The deadline is September 7, 2027. NIH typically takes 6-9 months from application to funding decision for R21 awards, though timing can vary by review cycle.
What research activities are supported?
The grant supports exploratory and developmental research on language development measurement tools, prediction models, validation studies, and methodological innovation. Preliminary data collection, tool development, and feasibility testing are typical activities.
What is the typical funding range for R21 awards?
R21 awards typically provide $150,000–$275,000 in direct costs per year for up to two years, though exact amounts vary by NIH institute and availability. Budget development must align with project scope and institutional overhead rates.
💡 Tips for applicants
- Build a strong methodological case: R21 is specifically about innovation in measurement and prediction. Emphasize what is novel about your measurement approach, validation strategy, or theoretical framework compared to existing methods.
- Develop preliminary data early: While R21 is exploratory, reviewers expect some preliminary evidence that your approach is feasible and promising. Pilot data, literature synthesis, or proof-of-concept results strengthen competitiveness.
- Focus on measurement outcomes: The grant title centers on "Advancement and Innovation in Measurement." Structure your aims and outcomes around developing, refining, or validating measurement instruments or predictive models, not just studying language development broadly.
- Ensure institutional research support: Confirm your institution has appropriate infrastructure (IRB, biostatistics support, research administration) and include letters of support from department leadership or your CTSA if applicable.
- Avoid clinical trial design: Even if your research touches clinical populations, frame your project as methodological development, validation, or feasibility testing rather than as a treatment trial. Clearly state why clinical trial design is not appropriate for your aims.
⚠️ Common mistakes
Applications are frequently rejected because they propose full clinical trials or intervention testing rather than exploratory measurement work, conflicting with the R21 "no clinical trials" restriction. Another common issue is insufficient preliminary data or justification for why the proposed measurement approach is truly novel versus existing methods. Finally, weak institutional research infrastructure documentation or unclear research administration/oversight capacity can signal inadequate support for the proposed work.
Similar grants
- OPEN 27-0343-10 FFY27 Local Agency General Non-Enforcement — Illinois Department of Transportation
- ROLLING Annual Agency Threshold Application Applicants for Funding Start Here — Texas City of Austin - Austin Public Health
- CLOSED Virginia’s Black Indigenous and People of Color (BIPOC) Grant – FY26 — Virginia The Virginia Department of Historic Resources
- ROLLING RTAP Grant Program (Rolling) — Virginia Department of Rail and Public Transportation
- ROLLING Rail Industrial Access Grant (RIA) — Virginia Department of Rail and Public Transportation